|
?:authorAffiliation
|
-
[\'Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.\', \'Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.\', \'Department of Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT, USA.\', \'Department of Biomedical Engineering, Yale School of Engineering & Applied Science, New Haven, CT, USA.\', \'Boyer Center for Molecular Medicine, Department of Microbial Pathogenesis, Yale University, New Haven, CT, USA.\', \'Department of Comparative Medicine, Yale University School of Medicine, New Haven, CT, USA.\', \'Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA.\', \'Department of Medicine, Section of Pulmonary and Critical Care Medicine, Yale University School of Medicine, New Haven, CT, USA.\', \'Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA.\', \'Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA.\', \'Yale Institute for Global Health, Yale University, New Haven, CT, USA.\', \'Yale School of Nursing, Yale University, Orange, CT, USA.\', \'Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA. akiko.iwasaki@yale.edu.\', \'Howard Hughes Medical Institute, Chevy Chase, MD, USA. akiko.iwasaki@yale.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}